Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 05 - 05 tags : Treatment save search
Oncocyte Completes Validation of TheraSure™ Transplant Monitor Test Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
Published: 2022-05-05 (Crawled : 20:00) - biospace.com/
OCX | News J | $2.495 -2.54% -2.61% 50K
|
Health Technology
|
| O: -1.65%
H: 5.88%
C: 0.0%
treatment test
VistaGen Announces Key Regulatory Update on PH94B for the Acute Treatment of Social Anxiety Disorder
Published: 2022-05-05 (Crawled : 19:00) - biospace.com/
VTGN | $4.77 1.49% 1.47% 150K
|
Health Technology
|
| O: 1.41%
H: 1.39%
C: -2.08%
ph94 treatment social anxiety disorder
Alzamend Neuro Announces Initiation of Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s
Published: 2022-05-05 (Crawled : 13:00) - biospace.com/
ALZN | $0.6894 -0.23% -0.23% 28K
|
Professional, Scientific, and T...
|
| O: 3.52%
H: 4.85%
C: 2.91%
al001 treatment dementia trial alzheimer’s alzheimer's
Moleculin Receives Allowance to Proceed with Phase 1/2 Study of Annamycin in Combination with Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
Published: 2022-05-05 (Crawled : 13:00) - biospace.com/
MBRX | $4.65 2.8% 2.72% 11K
|
Health Technology
|
| O: -0.64%
H: 0.65%
C: -3.87%
treatment leukemia phase 1 acute myeloid leukemia aml
Applied Therapeutics to Present Data on AT-007 Treatment in SORD Deficiency at the 2022 Annual Meeting of the Peripheral Nerve Society
Published: 2022-05-05 (Crawled : 12:20) - biospace.com/
APLT A | $4.4 -7.17% -7.73% 2.9M
|
Health Technology
|
| O: -0.25%
H: 0.5%
C: -4.48%
at-007 treatment therapeutics
Incyte Announces European Commission Approval of Jakavi® (ruxolitinib) as the First Post-Steroid Treatment for Acute and Chronic Graft-Versus-Host Disease
Published: 2022-05-05 (Crawled : 10:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.39%
H: 0.15%
C: -1.07%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 3.73%
H: 0.09%
C: -3.98%
jakavi treatment disease approval
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.